Evaluating the cost-effectiveness of pharmacological therapy in Alzheimer disease in Brazil (2025)
Price, Price Udo; Heggie, Robert; Moriguti, Júlio César 
; Pereira, Leonardo Régis Leira
Source: Value in Health Regional Issues. Unidades: FMRP, FCFRP
Subjects: IDOSOS, DOENÇA DE ALZHEIMER, FARMACOTERAPIA, ENZIMAS, SISTEMA NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRICE, Price Udo et al. Evaluating the cost-effectiveness of pharmacological therapy in Alzheimer disease in Brazil. Value in Health Regional Issues, v. 49, p. 1-8, 2025Tradução . . Disponível em: https://doi.org/10.1016/j.vhri.2025.101130. Acesso em: 20 abr. 2026.APA
Price, P. U., Heggie, R., Moriguti, J. C., & Pereira, L. R. L. (2025). Evaluating the cost-effectiveness of pharmacological therapy in Alzheimer disease in Brazil. Value in Health Regional Issues, 49, 1-8. doi:10.1016/j.vhri.2025.101130NLM
Price PU, Heggie R, Moriguti JC, Pereira LRL. Evaluating the cost-effectiveness of pharmacological therapy in Alzheimer disease in Brazil [Internet]. Value in Health Regional Issues. 2025 ; 49 1-8.[citado 2026 abr. 20 ] Available from: https://doi.org/10.1016/j.vhri.2025.101130Vancouver
Price PU, Heggie R, Moriguti JC, Pereira LRL. Evaluating the cost-effectiveness of pharmacological therapy in Alzheimer disease in Brazil [Internet]. Value in Health Regional Issues. 2025 ; 49 1-8.[citado 2026 abr. 20 ] Available from: https://doi.org/10.1016/j.vhri.2025.101130
